UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Prophylactic Central Compartment Lymph Node Dissection in Papillary Thyroid Carcinoma: Clinical Implications Derived From the First Prospective Randomized Controlled Single Institution Study

The journal of clinical endocrinology and metabolism, 2015-04, Vol.100 (4), p.1316-1324

2015

Volltextzugriff (PDF)

Targeted Therapy in Thyroid Cancer: State of the Art

Clinical oncology (Royal College of Radiologists (Great Britain)), 2017-05, Vol.29 (5), p.316-324

2017

Volltextzugriff (PDF)

Adrenal insufficiency in thyroid cancer patients treated with tyrosine kinase inhibitors and detected by ACTH stimulation test

Journal of endocrinological investigation, 2023-08, Vol.46 (8), p.1663-1671

2023

Volltextzugriff (PDF)

Osteonecrosis of the jaw: a rare but possible side effect in thyroid cancer patients treated with tyrosine-kinase inhibitors and bisphosphonates

Journal of endocrinological investigation, 2021-12, Vol.44 (12), p.2557-2566

2021

Volltextzugriff (PDF)

Radio-iodine refractory thyroid cancer patients: a tailored follow-up based on clinicopathological features

Journal of endocrinological investigation, 2023-10, Vol.46 (10), p.2165-2173

2023

Volltextzugriff (PDF)

Lenvatinib as a salvage therapy for advanced metastatic medullary thyroid cancer

Journal of endocrinological investigation, 2021-10, Vol.44 (10), p.2139-2151

2021

Volltextzugriff (PDF)

Real-life management and outcome of thyroid carcinoma-related bone metastases: results from a nationwide multicenter experience

Endocrine, 2018-01, Vol.59 (1), p.90-101

2018

Volltextzugriff (PDF)

New and old knowledge on differentiated thyroid cancer epidemiology and risk factors

Journal of endocrinological investigation, 2012, Vol.35 (6 Suppl), p.3-9

2012

Volltextzugriff (PDF)

Outcome of classical (CVPTC) and follicular (FVPTC) variants of papillary thyroid cancer: 15 years of follow-up

Endocrine, 2020-06, Vol.68 (3), p.607-616

2020

Volltextzugriff (PDF)

Correction to: Lenvatinib as a salvage therapy for advanced metastatic medullary thyroid cancer

Journal of endocrinological investigation, 2021-12, Vol.44 (12), p.2859-2859

2021

Volltextzugriff (PDF)

RET genetic screening of sporadic medullary thyroid cancer (MTC) allows the preclinical diagnosis of unsuspected gene carriers and the identification of a relevant percentage of hidden familial MTC (FMTC)

Clinical endocrinology (Oxford), 2011-02, Vol.74 (2), p.241-247

2011

Volltextzugriff (PDF)

In silico and in vitro analysis of rare germline allelic variants of RET oncogene associated with medullary thyroid cancer

Endocrine-related cancer, 2011-10, Vol.18 (5), p.603-612

2011

Volltextzugriff (PDF)

Recombinant Human Thyrotropin-Stimulated Serum Thyroglobulin Combined with Neck Ultrasonography Has the Highest Sensitivity in Monitoring Differentiated Thyroid Carcinoma

The journal of clinical endocrinology and metabolism, 2003-08, Vol.88 (8), p.3668-3673

2003

Volltextzugriff (PDF)

Classical point mutations of RET, BRAF and RAS oncogenes are not shared in papillary and medullary thyroid cancer occurring simultaneously in the same gland

Journal of endocrinological investigation, 2017, Vol.40 (1), p.55-62

2017

Volltextzugriff (PDF)

Outcome of differentiated thyroid cancer with detectable serum Tg and negative diagnostic (131)I whole body scan: comparison of patients treated with high (131)I activities versus untreated patients

The journal of clinical endocrinology and metabolism, 2001-09, Vol.86 (9), p.4092-4097

2001

Volltextzugriff (PDF)

Prediction of Disease Status by Recombinant Human TSH-Stimulated Serum Tg in the Postsurgical Follow-Up of Differentiated Thyroid Carcinoma

The journal of clinical endocrinology and metabolism, 2001-12, Vol.86 (12), p.5686-5690

2001

Volltextzugriff (PDF)

Celecoxib, a cyclooxygenase-2 inhibitor, potentiates the chemotherapic effect of vinorelbine in the medullary thyroid cancer TT cell line

Molecular and cellular endocrinology, 2012-05, Vol.355 (1), p.41-48

2012

Volltextzugriff (PDF)

Re-differentiation of thyroid carcinoma cell lines treated with 5-Aza-2′-deoxycytidine and retinoic acid

Molecular and cellular endocrinology, 2009-08, Vol.307 (1-2), p.142-148

2009

Volltextzugriff (PDF)

Contralateral Papillary Thyroid Cancer is Frequent at Completion Thyroidectomy with No Difference in Low- and High-Risk Patients

Thyroid (New York, N.Y.), 2001-09, Vol.11 (9), p.877-881

2001

Volltextzugriff (PDF)

Churches United to Stop HIV (CUSH): a faith-based HIV prevention initiative

Journal of the National Medical Association, 2005-07, Vol.97 (7 Suppl), p.60S-63S

2005

Volltextzugriff (PDF)

Successo terapeutico di Lenvatinib in seconda linea in un caso di carcinoma follicolare della tiroide avanzato

L'Endocrinologo, 2016, Vol.17 (5), p.266-267

2016

Volltextzugriff (PDF)

Strategies for reaching retirement communities and aging social networks: HIV/AIDS prevention activities among seniors in South Florida

Journal of acquired immune deficiency syndromes (1999), 2003-06, Vol.33 Suppl 2 (Sup 2), p.S238-S242

2003

Volltextzugriff (PDF)

Recombinant human TSH (rhTSH) in 2009: new perspectives in diagnosis and therapy

The quarterly journal of nuclear medicine and molecular imaging, 2009-10, Vol.53 (5), p.490

2009

Volltextzugriff (PDF)

RET protein expression has no prognostic impact on the long-term outcome of papillary thyroid carcinoma

European journal of endocrinology, 2001-11, Vol.145 (5), p.599-604

2001

Volltextzugriff (PDF)

Thyroid consequences of the Chernobyl nuclear accident

Acta Paediatrica, 1999-12, Vol.88 (s433), p.23-27

1999

Volltextzugriff (PDF)

1 – 25 von 139

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(113)
Mit Volltextzugriff
(120)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Prophylactic Central Compartment Lymph Node Dissection in Papillary Thyroid Carcinoma: Clinical Implications Derived From the First Prospective Randomized Controlled Single Institution Study

Targeted Therapy in Thyroid Cancer: State of the Art

Adrenal insufficiency in thyroid cancer patients treated with tyrosine kinase inhibitors and detected by ACTH stimulation test

Osteonecrosis of the jaw: a rare but possible side effect in thyroid cancer patients treated with tyrosine-kinase inhibitors and bisphosphonates

Radio-iodine refractory thyroid cancer patients: a tailored follow-up based on clinicopathological features

Lenvatinib as a salvage therapy for advanced metastatic medullary thyroid cancer

Real-life management and outcome of thyroid carcinoma-related bone metastases: results from a nationwide multicenter experience

New and old knowledge on differentiated thyroid cancer epidemiology and risk factors

Outcome of classical (CVPTC) and follicular (FVPTC) variants of papillary thyroid cancer: 15 years of follow-up

Correction to: Lenvatinib as a salvage therapy for advanced metastatic medullary thyroid cancer

RET genetic screening of sporadic medullary thyroid cancer (MTC) allows the preclinical diagnosis of unsuspected gene carriers and the identification of a relevant percentage of hidden familial MTC (FMTC)

In silico and in vitro analysis of rare germline allelic variants of RET oncogene associated with medullary thyroid cancer

Recombinant Human Thyrotropin-Stimulated Serum Thyroglobulin Combined with Neck Ultrasonography Has the Highest Sensitivity in Monitoring Differentiated Thyroid Carcinoma

Classical point mutations of RET, BRAF and RAS oncogenes are not shared in papillary and medullary thyroid cancer occurring simultaneously in the same gland

Outcome of differentiated thyroid cancer with detectable serum Tg and negative diagnostic (131)I whole body scan: comparison of patients treated with high (131)I activities versus untreated patients

Prediction of Disease Status by Recombinant Human TSH-Stimulated Serum Tg in the Postsurgical Follow-Up of Differentiated Thyroid Carcinoma

Celecoxib, a cyclooxygenase-2 inhibitor, potentiates the chemotherapic effect of vinorelbine in the medullary thyroid cancer TT cell line

Re-differentiation of thyroid carcinoma cell lines treated with 5-Aza-2′-deoxycytidine and retinoic acid

Contralateral Papillary Thyroid Cancer is Frequent at Completion Thyroidectomy with No Difference in Low- and High-Risk Patients

Churches United to Stop HIV (CUSH): a faith-based HIV prevention initiative

Successo terapeutico di Lenvatinib in seconda linea in un caso di carcinoma follicolare della tiroide avanzato

Strategies for reaching retirement communities and aging social networks: HIV/AIDS prevention activities among seniors in South Florida

Recombinant human TSH (rhTSH) in 2009: new perspectives in diagnosis and therapy

RET protein expression has no prognostic impact on the long-term outcome of papillary thyroid carcinoma

Thyroid consequences of the Chernobyl nuclear accident

Suchergebnisse filtern